1. Home
  2. PLSE vs CRTO Comparison

PLSE vs CRTO Comparison

Compare PLSE & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CRTO
  • Stock Information
  • Founded
  • PLSE 2014
  • CRTO 2005
  • Country
  • PLSE United States
  • CRTO France
  • Employees
  • PLSE N/A
  • CRTO N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CRTO Advertising
  • Sector
  • PLSE Health Care
  • CRTO Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • CRTO Nasdaq
  • Market Cap
  • PLSE 1.2B
  • CRTO 1.1B
  • IPO Year
  • PLSE 2016
  • CRTO 2013
  • Fundamental
  • Price
  • PLSE $13.33
  • CRTO $19.98
  • Analyst Decision
  • PLSE Buy
  • CRTO Buy
  • Analyst Count
  • PLSE 1
  • CRTO 9
  • Target Price
  • PLSE $22.00
  • CRTO $38.67
  • AVG Volume (30 Days)
  • PLSE 168.4K
  • CRTO 481.0K
  • Earning Date
  • PLSE 11-05-2025
  • CRTO 10-29-2025
  • Dividend Yield
  • PLSE N/A
  • CRTO N/A
  • EPS Growth
  • PLSE N/A
  • CRTO 83.79
  • EPS
  • PLSE N/A
  • CRTO 3.00
  • Revenue
  • PLSE $86,000.00
  • CRTO $1,956,800,000.00
  • Revenue This Year
  • PLSE N/A
  • CRTO N/A
  • Revenue Next Year
  • PLSE $700.00
  • CRTO $1.84
  • P/E Ratio
  • PLSE N/A
  • CRTO $6.61
  • Revenue Growth
  • PLSE N/A
  • CRTO 0.53
  • 52 Week Low
  • PLSE $12.56
  • CRTO $19.15
  • 52 Week High
  • PLSE $25.00
  • CRTO $47.27
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 31.82
  • CRTO 39.92
  • Support Level
  • PLSE $12.56
  • CRTO $19.15
  • Resistance Level
  • PLSE $13.46
  • CRTO $20.59
  • Average True Range (ATR)
  • PLSE 0.91
  • CRTO 0.87
  • MACD
  • PLSE -0.14
  • CRTO -0.20
  • Stochastic Oscillator
  • PLSE 20.67
  • CRTO 18.40

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

Share on Social Networks: